Early diagnosis of rheumatoid arthritis: an introduction to the newly designed Iran Criteria for Rheumatoid Arthritis.

about

Early diagnosis of rheumatoid arthritis: an introduction to the newly designed Iran Criteria for Rheumatoid Arthritis.

Item

http://www.wikidata.org/entity/Q47236458

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Early diagnosis of rheumatoid ...... eria for Rheumatoid Arthritis.

@en

Early diagnosis of rheumatoid ...... eria for Rheumatoid Arthritis.

@nl

type

Item

label

Early diagnosis of rheumatoid ...... eria for Rheumatoid Arthritis.

@en

Early diagnosis of rheumatoid ...... eria for Rheumatoid Arthritis.

@nl

prefLabel

Early diagnosis of rheumatoid ...... eria for Rheumatoid Arthritis.

@en

Early diagnosis of rheumatoid ...... eria for Rheumatoid Arthritis.

@nl

P1476

Early diagnosis of rheumatoid ...... eria for Rheumatoid Arthritis.

@en

P2093

Iraj Salehi

http://www.w3.org/2001/XMLSchema#string

Mohammad Khak

http://www.w3.org/2001/XMLSchema#string

Shabnam Khazaeli

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis.

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.

Rheumatoid arthritis: diagnosis and management.

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.

Prognostic laboratory markers of joint damage in rheumatoid arthritis.

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis.

P2888

s00296-011-2349-1

P304

45-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00296-011-2349-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51981102

http://www.w3.org/2001/XMLSchema#string

P698

22215043

http://www.w3.org/2001/XMLSchema#string